#Clinical Trials
20 articles with this tag
Google DeepMind's AI clinician aims to aid doctors
Google DeepMind is developing an AI co-clinician to assist doctors, improve patient care, and address healthcare worker shortages, exploring multimodal interactions.
Databricks Aims to Speed Up Drug Trials
Databricks Genie aims to slash clinical trial delays by enabling natural language interrogation of complex data, speeding up treatment approvals and patient access.
TriNetX Speeds Drug Trials With Databricks
TriNetX uses Databricks' AI platform to significantly speed up drug development, cutting trial delays and improving research efficiency.
Sonomind Funding Fuels €3M Push for Novel Brain Stimulation
\n Paris-based Sonomind , a company at the forefront of non-invasive brain stimulation, has successfully secured €3 million ($3.53M).
Sonomind Funding Fuels €3M Push for Novel Brain Stimulation
\n Paris-based Sonomind , a company at the forefront of non-invasive brain stimulation, has successfully secured €3 million ($3.53M).
Treeline Biosciences Raises $200M, Initiates Clinical Trials
The company also initiated Phase 1 trials for three oncology programs, including a pan-KRAS inhibitor.
Mabylon Raises €31.8M to Advance Allergy Antibody Pipeline
Mabylon, a Swiss biotech, secured €31.8 million in new funding. This investment will advance its lead peanut allergy program and early-stage pipeline. The funding came from existing private investors, including former Roche management and board members.
Mabylon Raises €31.8M to Advance Allergy Antibody Pipeline
Zurich-based Mabylon , a Swiss biotech scale-up, secured €31.8 million in new funding. This Mabylon funding round will advance its lead peanut allergy program.
Comphya Secures €8M Series A for ED Neurostimulation
\n Lausanne-based Comphya SA , a clinical-stage MedTech company, recently closed an oversubscribed Series A financing round, raising €8 million.
Comphya Secures €8M Series A for ED Neurostimulation
\n Lausanne-based Comphya SA , a clinical-stage MedTech company, recently closed an oversubscribed Series A financing round, raising €8 million.
CNBC Disruptor 50 on Formation Bio to Redefine Drug Development
Neuralink Secures Massive $650M Series E Funding
Vivodyne Secures $40 Million to Revolutionize Drug Discovery
Veltist Secures €160,000 in Funding for Innovative Surgical Patch
Veltist, a medtech startup spun out of ETH Zurich and Empa, has successfully raised €160,000 (CHF 150,000) in seed funding from Venture Kick.
Veltist Secures €160,000 in Funding for Innovative Surgical Patch
Veltist, a medtech startup spun out of ETH Zurich and Empa, has successfully raised €160,000 (CHF 150,000) in seed funding from Venture Kick.
MaxisIT Evolves to Maxis AI, Launches Enterprise-Ready Agentic AI Platform to Transform Clinical Trials in Pharmaceutical and Life Sciences Industry
Zetaris Launches AI Clinical Assistant for Improved Healthcare Outcomes
AI and Spatial Biology Startup Nucleai Secured $14 Million Led by M Ventures
Accenture Ventures Backs QuantHealth, Clinical Trial Simulations
